United States v. Mehdi Nikparvar-Fard
Opinion
NOT PRECEDENTIAL
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT
No. 23-3270
UNITED STATES OF AMERICA
v.
MEHDI NIKPARVAR-FARD,
a/k/a MEHDI ARMANI,
Appellant
On Appeal from the United States District Court for the Eastern District of Pennsylvania (D.C. No. 2:18-cr-00101-001)
District Judge: Honorable Gene E.K. Pratter
Submitted Pursuant to Third Circuit L.A.R. 34.1(a)
January 13, 2025
Before: PHIPPS, FREEMAN, and CHUNG, Circuit Judges (Filed: February 12, 2025)
OPINION*
PHIPPS, Circuit Judge.
A federal grand jury indicted a medical doctor who owned and operated four Philadelphia-area urgent care facilities on five counts related to the illegal distribution of
*
This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not constitute binding precedent.
opioids. In return for a lower sentencing range, the doctor pleaded guilty to one of the counts: conspiracy to distribute a controlled substance. One of the doctor’s employees, a
physician assistant, was also indicted on four of those five counts, including conspiracy.
Unlike the doctor, the physician assistant did not plead guilty; instead, he went to trial and was not convicted of any of the charges against him. After his alleged co-conspirator’s
trial ended without a conviction, the doctor changed his mind about his prior guilty plea, and he twice moved to withdraw it. The District Court denied those motions and imposed a prison sentence within the range specified in the plea agreement. The doctor now appeals the denial of his second withdrawal-of-plea motion. On abuse-of-discretion review, we
will affirm that ruling.
FACTUAL BACKGROUND
Between January 2014 and August 2017, Dr. Mehdi Nikparvar-Fard owned and operated eight urgent care facilities, four of which were in the Philadelphia area. Each facility was identified by the prefix ‘AUC,’ an abbreviation for ‘Advanced Urgent Care,’ followed by a location, such as ‘AUC – City Avenue’ or ‘AUC – Montgomeryville.’ After a federal investigation of several of his urgent care facilities, a grand jury indicted Nikparvar-Fard on March 14, 2018, for one count of conspiracy to unlawfully distribute oxycodone. He was then taken into custody, where he remained for over 42 months before
being released in July 2022 on a $100,000 cash bond.
On January 9, 2019, while Nikparvar-Fard was detained, a grand jury returned a
superseding indictment. It charged him with five counts related to the illegal distribution
of opioids: four counts of maintaining drug-involved premises – one count for each of AUC’s Philadelphia-area locations, see 21 U.S.C. § 856(a)(1) – and one count of
conspiracy to unlawfully distribute oxycodone, see id. § 841(a)(1), (b)(1)(C); id. § 846.
That superseding indictment also charged twelve employees of AUC facilities – seven physicians, four physician assistants, and the office manager – with between one and four
counts of maintaining a drug-involved premises. One of the physician assistants, Mitchell
White, was charged with three counts of maintaining a drug-involved premises, see 21 U.S.C. § 856(a)(1), as well as the conspiracy count, see id. § 841(a)(1), (b)(1)(C); id.
§ 846.
As the case proceeded, the Government dismissed charges against six of the defendants, and five defendants pleaded guilty to the charges against them. Even still, up until three days before the scheduled trial date of January 9, 2023, two defendants –
Nikparvar-Fard and White – had not been dismissed and had not pleaded guilty.
On January 6, 2023, however, Nikparvar-Fard came to court to plead guilty to the
conspiracy charge. He had previously entered into a plea agreement with the Government under which the Government agreed to dismiss the remaining four charges. In addition, the sentencing range in the plea agreement – 43 to 108 months’ imprisonment – was less than the applicable range under the United States Sentencing Guidelines of 121 to 151 months. See U.S. Sent’g Guidelines Manual ch. 5 pt. A (U.S. Sent’g Comm’n 2023) (setting forth a 121 to 151 month sentence for a total offense level of 31 and criminal history category of II). The parties further agreed to present the plea agreement pursuant
to Federal Rule of Criminal Procedure 11(c)(1)(C) so that if the District Court accepted the plea, it would be bound by that reduced sentencing range.
The District Court accepted that plea and the reduced sentencing range that came
with it. Before it did so, the District Court made several inquiries to ensure that a factual basis existed for Nikparvar-Fard’s guilty plea, see Fed. R. Crim. P. 11(b)(3) (“Before
entering judgment on a guilty plea, the court must determine that there is a factual basis for
the plea.”), and that the plea was voluntary, knowing, and intelligent, see Bradshaw v. Stumpf, 545 U.S. 175, 183 (2005) (“A guilty plea operates as a waiver of important rights,
and is valid only if done voluntarily, knowingly, and intelligently, ‘with sufficient
awareness of the relevant circumstances and likely consequences.’” (quoting Brady v. United States, 397 U.S. 742, 748 (1970))). With respect to the factual basis for Nikparvar-
Fard’s guilty plea, the Government explained that the conspiracy charge was based on his practice, at various times between May 2014 and July 2015, of giving a pre-signed prescription pad to another physician who did not have a license to write prescriptions and that such a practice was “outside the usual course of professional practice and not for a
legitimate medical purpose.” Change-of-Plea Hr’g Tr. 41:22–23 (App. 163). Nikparvar- Fard fully admitted those facts. Through a series of questions, which Nikparvar-Fard
answered under oath, the District Court ensured that he was not making a haphazard or half-hearted admission: it confirmed that he had sufficient time and opportunity to discuss his case with counsel, that he was satisfied with their representation and advice, and that no one had made “any threats or any promises or assurances to [him] of any kind other than what is set forth in the Plea Agreement” to induce his plea. Id. at 31:23–32:1 (App. 152– 53).
The next week, the lone remaining defendant, White, proceeded to trial on the four
counts against him. The trial ended with a mistrial on the conspiracy-to-distribute charge and acquittals on the three counts of maintaining a drug-involved premises.
Two days later, Nikparvar-Fard filed a pro se motion to withdraw his guilty plea.
Contrary to his testimony during the plea colloquy, Nikparvar-Fard asserted that his counsel had threatened him: if he did not either plead guilty or satisfy counsel’s demand
for an additional payment of $190,000 for trial, then his counsel would stop representing
him. After the filing of that motion, Nikparvar-Fard’s counsel moved to withdraw from representing him. The District Court granted counsel’s motion to withdraw from
representation, denied without prejudice Nikparvar-Fard’s motion to withdraw the guilty
plea, and appointed new counsel.
Through his appointed counsel, Nikparvar-Fard again moved to withdraw his guilty
plea. There, he argued that he was under duress when he pleaded guilty due to his prior counsel’s pre-trial fee demand. In addition, he claimed that his prior counsel provided ineffective assistance because they were critical of his desire to prove that he did not act with criminal intent when he gave the unlicensed doctor pre-signed pads to write
prescriptions for opioids. Cf. generally Ruan v. United States, 597 U.S. 450, 454 (2022) (holding that a conviction under 21 U.S.C. § 841 for dispensing controlled substances not
as authorized requires a knowing or intentional mental state).
Free access — add to your briefcase to read the full text and ask questions with AI
United States v. Mehdi Nikparvar-Fard (United States v. Mehdi Nikparvar-Fard) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.